Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins. - Wikidata - wikimedia - TriplyDB

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.

http://www.wikidata.org/entity/Q35108258

about

In vivo microRNA-155 expression influences antigen-specific T cell-mediated immune responses generated by DNA vaccination Novel epigallocatechin gallate analogs as potential anticancer agents: a patent review (2009 - present)Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus A combined nucleocapsid vaccine induces vigorous SARS-CD8+ T-cell immune responses.Novel immunotherapeutic strategies of gastric cancer treatment Antigen-specific immunotherapy of cervical and ovarian cancer Inhibition of activation-induced death of dendritic cells and enhancement of vaccine efficacy via blockade of MINOR Prospects for developing an effective particle-mediated DNA vaccine against influenza.Herpes simplex virus type 2 vaccines: new ground for optimism?Improvement of cytomegalovirus pp65 DNA vaccine efficacy by co-administration of siRNAs targeting BAK and BAX Enhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA.Enhancement of DNA vaccine potency through coadministration of CIITA DNA with DNA vaccines via gene gun.Construction and characterization of calreticulin-HBsAg fusion gene recombinant adenovirus expression vector.Therapeutic HPV DNA vaccines.Immunotherapy for cervical cancer: Research status and clinical potential Inhibitory RNA molecules in immunotherapy for cancer.Efficient delivery of DNA vaccines using human papillomavirus pseudovirions Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγ Enhancement of protein vaccine potency by in vivo electroporation mediated intramuscular injection.Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer.Combination of viral oncolysis and tumor-specific immunity to control established tumors Modulation of plasmid DNA vaccine antigen clearance by caspase 12 RNA interference potentiates vaccination.DNA vaccines and apoptosis: to kill or not to kill?DNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunity Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope Modulation of SIV and HIV DNA vaccine immunity by Fas-FasL signaling Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination.DNA vaccines for cervical cancer: from bench to bedside.Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life and intracellular targeting strategies with a strategy to boost CD4+ T cell.Preventative and therapeutic vaccines for cervical cancer.Gastric cancer and the epoch of immunotherapy approaches Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination.Particle-mediated DNA vaccine delivery to the skin.DNA fusion gene vaccines against cancer: from the laboratory to the clinic.Therapeutic Vaccine Strategies against Human Papillomavirus.Intradermal administration of DNA vaccines combining a strategy to bypass antigen processing with a strategy to prolong dendritic cell survival enhances DNA vaccine potency.DNA vaccines, electroporation and their applications in cancer treatment CD4 T cell-induced, bid-dependent apoptosis of cutaneous dendritic cells regulates T cell expansion and immune responses.Human papillomavirus type 16 E5 protein as a therapeutic target.

P2860

Q21195875-611C8983-4CF1-4EC3-AADA-5483FEE7770B Q24595211-9C48360B-1B89-46EA-904F-9E243782B7E1 Q24658311-418BD98A-3DF7-4D82-95BF-206B4B1C1753 Q24816925-ECD3E6E5-88C9-4497-A5B2-1CABCE203418 Q27011232-77033BD0-9BD4-4162-9B7D-64FC0398D0E6 Q27488697-495C8D58-BB14-43F6-9086-E3F3091BF091 Q28589679-28D540F5-F1D8-4D3A-9397-C0E09EE944D6 Q30380300-C03A651F-95B5-4F4E-8EBD-8FFB8D5706D6 Q33711912-C2FD5576-40B0-4C86-B2CD-6CCE0B3B49C4 Q33744024-5ADB3F4C-607B-4212-A027-0BB98720BC46 Q33778143-297E5963-CC63-4BC6-89E3-0C2654B59F83 Q33860104-0E02A335-270D-4C50-9FC8-CDB946037F78 Q33935644-115E6861-9283-4B7D-8270-57091B8D1184 Q33936427-7F00FE1A-2BE5-423C-8FDD-8911384CD49F Q34033763-6C9D0EDB-8351-46EE-A811-0723B26A85BE Q34033910-30B234BD-8E5E-4593-9B0F-CE55A1CC0379 Q34274080-93C4FE10-F84A-4BBB-94AF-0C16ACA7FE80 Q34438411-BE7FBB9A-F0A4-425E-83E3-61246B3173D6 Q34516610-E5CE5EFB-FCA9-4ECC-9F9F-42636BF84604 Q34544154-EC86EBE5-B4B5-4C8D-89C9-99D2621D02B7 Q34793516-A02758D3-2FBE-46B9-985B-5BD25235126E Q35066303-7C46BACF-2DF9-431B-85B8-79BF6CEBFAA8 Q35108541-1C429887-3582-47F0-AC56-2263C4715B16 Q35184078-838C6F29-76F7-430E-9325-C6B133238A88 Q35230184-09166C61-FD49-4813-B990-39C735727F59 Q35232840-CDD2402A-E25E-40F5-990C-A212A50B8CB1 Q35234876-E37ED315-912F-43E3-BD03-833F1A80BBD4 Q35234948-78775FCC-3B71-4F2F-B138-8337F0410990 Q35234992-ACB8568B-FBC7-4C76-9F54-CB9B920A5665 Q35401109-41FD999B-90D5-4240-ACC0-9F288FAB9D8A Q35623323-60F0DA64-287C-4A02-A4E3-B4491E7511BC Q35625349-E8FB1946-886B-48B6-A9DA-DA5E58A00E4E Q35782004-30ED3CA2-62FA-4E95-9494-AB97449F9DDD Q35790864-C1638679-8A39-4D85-AE2F-DC89EFD424AC Q35826392-FAB854E3-14FD-459A-BB62-E37E58A24015 Q35826752-8F675587-9A70-403D-9399-920FDA4203D1 Q36248706-2EEFAF62-3062-4C97-BD5C-A42A91AEBA17 Q36256459-68C79881-7A24-4C5A-B5F9-67A3378FFE57 Q36303053-54A450FC-4392-43BC-945F-F8208BBBC4A4 Q36406751-53BE882A-80A1-4FC1-AA1D-59A150E33FAD

P2860

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.

http://www.wikidata.org/entity/Q35108258

description

2003 nî lūn-bûn

@nan

2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.

@ast

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.

@en

type

label

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.

@ast

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.

@en

prefLabel

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.

@ast

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.

@en

P1433

Q35108258-99C36901-0120-415E-93B3-B7AC72BC6DA2

P1476

Q35108258-BA0CFC77-8659-4B84-94FD-1BBED768E125

P2093

Q35108258-67B1D1E4-333E-47FB-90EB-39494C476950

Q35108258-7099B7C6-CDC0-4BA7-8147-167C273D7DAF

Q35108258-9920A2C8-C765-4BA5-B130-FFC40C3D01C8

Q35108258-9A8FFB0B-FBD8-493C-BE15-B583B152D62A

Q35108258-C3FC8A00-8A2E-4D39-A964-3CA34EC42693

Q35108258-F6138EA9-5FCC-4E73-B391-094F94F07415

P2860

Q35108258-056D7141-DE0F-4DDD-946B-D4B43BE97A2F

Q35108258-15D6154A-328C-46FB-9FAD-EC215F2D5786

Q35108258-192F8C42-AE23-40E2-A2FC-4720A94EB713

Q35108258-1ED4DE03-1885-4C41-9AA3-FEF9610F16BD

Q35108258-33B092B0-48D2-4CF9-AA8E-52CA7555A1D6

Q35108258-379A4A1C-E953-495E-BA4E-CF27A9BF9187

Q35108258-385E2693-A9F4-46AF-B9DD-82F054B0DC2C

Q35108258-486B3F09-BD43-42D8-878D-5C5020A1CF1E

Q35108258-50DC21CA-A858-473C-98A7-C4102CE7D02D

Q35108258-5FA883FA-0472-4F8E-A40A-FEF6CF1ECD4F

P304

Q35108258-A876A3EA-ACA6-4426-B417-4F549523FB9A

P31

Q35108258-428A200F-D001-4451-B53E-4D5673B6CF63

P356

Q35108258-5F2B2176-FE06-419B-B86C-0DDB8AD2FFCE

P407

Q35108258-34E64638-A15F-43C9-884B-F7283DDA76BA

P433

Q35108258-DECE1234-53CA-495C-94E9-8158DAE8C239

P478

Q35108258-E0D69CAB-6FA8-4706-8912-35364969A1DA

P50

Q35108258-CF93CE26-2271-495F-81EE-CE42BC677F0C

Q35108258-F4419CF9-99DF-4D4F-9913-A3ED8E74AE2A

P577

Q35108258-40497710-B38C-40C6-BF6E-290921928BB5

P698

Q35108258-A1385710-CE51-47D6-924F-D41FB71E1BB4

P932

Q35108258-3F46936F-9222-4680-875D-6352AD77462D

P356

P1433

Journal of Clinical Investigation

P1476

Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins.

@en

P2093

Chien-Fu Hung

http://www.w3.org/2001/XMLSchema#string

J Marie Hardwick

http://www.w3.org/2001/XMLSchema#string

Jeremy Juang

http://www.w3.org/2001/XMLSchema#string

Liangmei He

http://www.w3.org/2001/XMLSchema#string

T-C Wu

http://www.w3.org/2001/XMLSchema#string

Tae Woo Kim

http://www.w3.org/2001/XMLSchema#string

P2860

A Toll-like receptor recognizes bacterial DNA

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

X-linked IAP is a direct inhibitor of cell-death proteases

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition

CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme

Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins

Bcl-2 and Bcl-xL inhibit CD95-mediated apoptosis by preventing mitochondrial release of Smac/DIABLO and subsequent inactivation of X-linked inhibitor-of-apoptosis protein

Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

P304

109-117

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI200317293

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12840065

http://www.w3.org/2001/XMLSchema#string

P932

162284

http://www.w3.org/2001/XMLSchema#string